BioSeek Inc.
This article was originally published in Start Up
Executive Summary
The founders of BioSeek had experienced first-hand a major challenge facing the pharmaceutical industry before forming the company: how to assess unvalidated targets and hit compounds binding to those targets. They had little confidence in existing methods used for determining how well these targets and their compounds would influence human biology or perform in clinical trials. They collaborated to solve this problem--which continues to vex biotech and pharmaceutical firms alike.